KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBITDA Margin (2020 - 2026)

Organon has reported EBITDA Margin over the past 7 years, most recently at 16.1% for Q1 2026.

  • For Q1 2026, EBITDA Margin rose 30.0% year-over-year to 16.1%; the TTM value through Mar 2026 reached 18.29%, down 275.0%, while the annual FY2025 figure was 18.19%, 1556.0% up from the prior year.
  • EBITDA Margin for Q1 2026 was 16.1% at Organon, up from 13.93% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 25.98% in Q3 2024 and troughed at 36.23% in Q4 2023.
  • A 5-year average of 3.77% and a median of 7.59% in 2022 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: crashed -1752bps in 2023 and later soared 6100bps in 2024.
  • Year by year, EBITDA Margin stood at 32.53% in 2022, then fell by -11bps to 36.23% in 2023, then skyrocketed by 150bps to 18.09% in 2024, then dropped by -23bps to 13.93% in 2025, then increased by 16bps to 16.1% in 2026.
  • Business Quant data shows EBITDA Margin for OGN at 16.1% in Q1 2026, 13.93% in Q4 2025, and 22.35% in Q3 2025.